July 2018
Volume 59, Issue 9
ARVO Annual Meeting Abstract  |   July 2018
The mechanism study and biomarker screening of vireous for rhegmatogenous retinal detachment associated with choroidal detachment
Author Affiliations & Notes
  • zhifeng wu
  • Footnotes
    Commercial Relationships   zhifeng wu, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4241. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      zhifeng wu; The mechanism study and biomarker screening of vireous for rhegmatogenous retinal detachment associated with choroidal detachment
      . Invest. Ophthalmol. Vis. Sci. 2018;59(9):4241.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Our aim was to identify obvious different metabolites, proteins and related pathways to elucidate the etiology of rhegmatogenous retinal detachment associated with choroidaldetachment (RRDCD) so as to provide direction toward diagnosis and treatment of RRDCD.

Methods : We used a liquid chromatography-quadrupole-time-of-flight/mass spectrometer(LC-Q-TOF/MS) to obtain the metabolome from the vitreous tissue of patients withRRD and RRDCD. The metabolomes from 29 samples(14 from RRD patients and 15 from RRDCD patients) were analyzed bySIMCA-P. A one-way analysis ofvariance with a Bonferroni correction was used to test significance. The BiofluidMetabolitesDatabase and Human Metabolome Database were used to identify ions.16 vitreous samples were analysised by proteomic based on iTRAQ analysis.Proteins were analyzed by capillary high performance liquid chromatography identification and electrospray ion trap mass spectrometry after FASP digestion and iTRAQ labeling. Bioinformatics analysis were performed using Maxquant software, GO software and KEGG pathways database . The screening criteria was Ratio>+/-1.2 and P value<0.05.

Results : The PLS-DA identified 265 (variable importance in the project >1) ions whose levels were significantly different in vitreous from patients with RRD and RRDCD. Among the 265ions, 24 (23 observed in the positive mode and 1 observed in the negative mode) were identified by searching MS and MS/MS fragments in the Biofluid Metabolites Database andHuman Metabolome Database. Metabolites found were associated with pathways related to proliferation, inflammatory reactions, and hemodynamic changes. In proteomics, a total of 2510 peptides and 750 proteins were identified.There were103 differentially expressed proteins(Ratio>+/-1.2 and P <0.05.), among which 49 proteins were up regulated and 54 proteins were down regulated. Most of the differentially expressed proteins were located in extracellular space.KEGG pathway analysis suggested that proteins related to complement and coagulation cascades were significantly enriched.

Conclusions : Metabolites and proteomes have been identified that were present in vitreous at significantly different levels between RRDCD and RRD. These metabolites and proteomes are likely to be involved in the pathology of each disease and may potentially be used to diagnose and treat RRDCD and RRD.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.